REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gene Security Network, Inc. (GSN) announced today the introduction of the All Chromosome Aneuploidy Screening test, powered by Parental Support™ bioinformatics. This is the first commercially available test to leverage bioinformatics to inform in vitro fertilization (IVF) transfer decisions by identifying potential abnormalities across all 24 chromosomes (aneuploidy) from a single embryonic cell. Test results are available within 24 hours and have an accuracy rate exceeding 99% for the cell tested.
